Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Natalizumab (ausschl. in der Dafo. Injektionslösung, ATC L04AA23 für die Zeit 01.09.24 - 31.08.26
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Contract value
- no value published
- Bids received
- 5
- Published
- 2 Sept 2026
- Awarded
- 1 Sept 2024
- Contract start
- 1 Sept 2024
- Contract end
- 19 Sept 2025estimated
- Region
- Hamburg